期刊文献+

腹腔镜与开腹再次肝切除术治疗复发性肝细胞癌的安全性及疗效对比 被引量:11

Comparision between laparoscopic hepatectomy and open hepatectomy for recurrent hepatocellular carcinoma
原文传递
导出
摘要 目的比较开腹再次肝切除术(ORH)与腹腔镜再次肝切除术(LRH)治疗复发性肝细胞癌(HCC)的安全性及疗效。方法回顾分析2015年8月至2017年12月南方医科大学南方医院复发性HCC行再次肝切除术33例患者资料,男性24例,女性9例。根据再次手术方式分为ORH组(18例),LRH组(15例)。比较两组术前资料、手术相关指标以及术后指标。结果两组前次肝切除范围、两次手术间隔时间、肿瘤数目、肿瘤最大直径等术前资料比较,差异无统计学意义(P>0.05)。两组肝切除方式、肝门阻断比例及手术持续时间比较,差异无统计学意义(P>0.05)。LRH组术中出血量低于ORH组[(66.7±36.3)ml比(251.1±75.6)ml],差异有统计学意义(P<0.05)。两组住院费用、术后首次白细胞计数、术后并发症比较,差异无统计学意义(P>0.05)。与ORH组比较,LRH组术后首次中性粒细胞百分比[(88.2±3.7)%比(83.6±4.8)%]、住院时间[(9.8±3.7)d比(6.3±2.9)d]及恢复进食时间[(2.9±1.4)d比(1.2±0.4)d]减少,差异有统计学意义(P<0.05)。结论LRH是治疗复发性HCC安全、有效的外科手段,并在减少术中出血量、促进术后恢复进食、缩短住院时间方面有一定优势。 Objective To compare the safety and short-term efficacy of laparoscopic repeat hepatectomy (LRH) with open repeat hepatectomy (ORH) for recurrent hepatocellular carcinoma (rHCC). Methods The clinical data of 33 patients with rHCC who underwent hepatectomy at Nanfang Hospital, Southern Medical University from August 2015 to November 2017 were retrospectively analyzed. There were 24 males and 9 females. The patients were divided into LRH group (n=15) and ORH group (n=18). The preoperative clinical data, operative and postoperative data of the two groups were compared. ResultsNo significant differences were observed in the preoperative clinical data of the two groups, including the extent of the previous hepatectomy, the interval between the two surgeries, the number of tumors, and the maximum diameter of tumors. No significant differences were observed in the liver resection method, portal occlusion time and operation duration between the two groups. Blood loss was significantly lower in the LRH group [(66.7±86.1)ml vs.(251.1±75.6)ml, P<0.05]. The total hospitalization expenses, first postoperative white blood cell count, and hepatic insufficiency in the two groups were not significantly different (P>0.05). The postoperative diet recovery was significantly shorter (1.2±0.4) days vs.(2.9±1.4) days, the inflammation indicator NEU% was significantly decreased (83.6±4.8)% vs.(88.2±3.7)%, and the length of postoperative hospital stay (6.3±2.9) days vs.(9.8±3.7)days was significantly shorter in the LRH group (P<0.05). Conclusions LRH was safe and effective in the treatment of rHCC, LRH was superior in reducing intraoperative blood loss, promoting postoperative recovery and shortening hospital stay when compared to ORH.
作者 陈雪芳 谢浩荣 王恺 张起帆 周杰 Chen Xuefang;Xie Haorong;Wang Kai;Zhang Qifan;Zhou Jie(Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China)
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2019年第3期175-178,共4页 Chinese Journal of Hepatobiliary Surgery
关键词 肝切除术 肝细胞 复发 腹腔镜 Hepatectomy Carcinoma, hepatocellular Recurrence Laparoscopes
  • 相关文献

参考文献3

二级参考文献27

  • 1Chung-Bao Hsieh, Teng-Wei Chen, Division of General Sur-gery, Tri-Service General Hospital, Taipei 114, Taiwan, China Chung-Bao Hsieh, Kuo-Piao Chung, Graduate Institute of Health Care Organization Administration, National Taiwan University, Taipei 100, Taiwan, China Chi-Ming Chu, Section of Biostatistics and Informatics, De-partment of Epidemiology, School of Public Health, National Defense Medical Center, Taipei 114, Taiwan, ChinaHeng-Cheng Chu, Department of Internal Medicine, Tri-Service General Hospital, Taipei 114, Taiwan, ChinaCheng-Ping Yu, Department of Pathology, Tri-Service General Hospital, Taipei 114, Taiwan, China.Is inconsistency of α-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?[J].World Journal of Gastroenterology,2010,16(24):3049-3055. 被引量:11
  • 2Zou, Wei-Long,Zang, Yun-Jin,Chen, Xin-Guo,Shen, Zhong-Yang.Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2008,7(2):145-151. 被引量:17
  • 3Wu CC,Cheng SB,Yeh DC,et al.Second and third hepatectomies for recurrent hepatocellular carcinoma are justified[J].Br J Surg,2009,96:1049-1057. 被引量:1
  • 4Bruix J,Sherman M,American Association for the Study of Liver Diseases.Management of hepatocellular carcinoma:an update[J].Hepatology,2011,53 (3):1020-1022. 被引量:1
  • 5Kishi Y,Saiura A,Yamamoto J,et al.Repeat treatment for recurrent hepatocellular carcinoma:is it validated?[J].Langenbecks Arch Surg,2011,396 (7):1093-1100. 被引量:1
  • 6Nguyen KT,Gamblin TC,Geller DA.World review of laparoscopic liver resection-2,804 patients[J].Ann Surg,2009,250 (5):831-841. 被引量:1
  • 7Reddy SK,Tsung A,Geller DA.Laparoscopic liver resection[J].World J Surg,2011,35(7):1478-1486. 被引量:1
  • 8Viganò L,Tayar C,Laurent A,et al.Laparoscopic liver resection:a systematic review[J].J Hepatobiliary Pancreat Surg,2009,16(4):410421. 被引量:1
  • 9Belli G,Cioffi L,Fantini C,et al.Laparoscopic redo surgery for recurrent hepatocellular carcinoma in cirrhotic patients:feasibility,safety,and results[J].Surg Endosc,2009,23 (8):1807-1811. 被引量:1
  • 10Hu M,Zhao G,Xu D,et al.Laparoscopic repeat resection of recurrent hepatocellular carcinoma[J].World J Surg,2011,35(3):648-655. 被引量:1

共引文献51

同被引文献109

引证文献11

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部